{
  "zip": "141 22",
  "sector": "",
  "fullTimeEmployees": 9,
  "longBusinessSummary": "Medivir AB (publ) researches, develops, and sells pharmaceuticals primarily for the treatment of oncology. The company markets Xerclear for use in the treatment of labial herpes under the Zoviduo name. It develops Remetinostat, which has completed phase II clinical trial for treating cutaneous T-cell lymphoma, as well as in phase II clinical trial for treating basal cell carcinoma; and Birinapant that is in phase II clinical trial for treating colorectal cancer. The company also develops MIV-818, which is in phase Ia clinical trial for treating liver cancer; MIV-828, a candidate drug for treating blood cancer; MIV-711, which is in phase II clinical trial for treating osteoarthritis; and MIV-802, a nucleotide-based drug candidate for treating hepatitis C infections. It sells its products in Sweden, the Nordic region, Europe, the United States, and the rest of the world. The company has a research collaboration with the Drug Discovery and Development Platform and SciLifeLab for the discovery of antivirals for SARS CoV-2. Medivir AB (publ) was founded in 1988 and is based in Huddinge, Sweden.",
  "city": "Huddinge",
  "phone": "46 8 54 68 31 00",
  "country": "Sweden",
  "companyOfficers": [],
  "website": "http://www.medivir.com",
  "maxAge": 1,
  "address1": "Lunastigen 7",
  "industry": "",
  "previousClose": 1.10027,
  "regularMarketOpen": 1.34,
  "twoHundredDayAverage": 1.5190648,
  "trailingAnnualDividendYield": null,
  "payoutRatio": null,
  "volume24Hr": null,
  "regularMarketDayHigh": 1.100274,
  "navPrice": null,
  "averageDailyVolume10Day": 512,
  "totalAssets": null,
  "regularMarketPreviousClose": 1.10027,
  "fiftyDayAverage": 1.2609091,
  "trailingAnnualDividendRate": null,
  "open": 1.34,
  "averageVolume10days": 512,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 0.104187,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 1.100274,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 115,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 36635736,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 476,
  "priceToSalesTrailing12Months": null,
  "dayLow": 1.100274,
  "ask": null,
  "ytdReturn": null,
  "askSize": null,
  "volume": 115,
  "fiftyTwoWeekHigh": 1.85,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.95,
  "bid": null,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": null,
  "dayHigh": 1.100274,
  "exchange": "PNK",
  "shortName": "MEDIVIR AB",
  "longName": "Medivir AB (publ)",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "MVRBF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_2480879",
  "uuid": "83986397-875c-3d7e-a910-44e7a5093dc9",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 24288000,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": null,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": 0.22627,
  "netIncomeToCommon": null,
  "trailingEps": null,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0.13735,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1601424000,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 22431182,
  "enterpriseValue": 32545920,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 1.34,
  "logo_url": "https://logo.clearbit.com/medivir.com"
}